Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • IL Receptor
    (1)
  • Interleukin
    (1)
  • MMP
    (1)
  • NF-κB
    (1)
  • Parasite
    (1)
  • TNF
    (1)
  • Others
    (5)
TargetMol | Tags By ResearchField
  • Immune System
    (2)
  • Inflammation
    (2)
  • Metabolism
    (2)
  • Cancer
    (1)
  • Infection
    (1)
Filter
Search Result
Results for "

interleukin 1beta

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Natural Products
    1
    TargetMol | Natural_Products
  • Recombinant Protein
    12
    TargetMol | Recombinant_Protein
  • Antibody Products
    8
    TargetMol | Antibody_Products
Interleukin 1beta
T21048117027-34-6
Interleukin 1beta is a bioactive chemical.
  • $1,520
6-8 weeks
Size
QTY
Menthone
T566010458-14-7
Menthone has anti-inflammary activity,, it can suppress the lipopolysaccharide (LPS)-induced proinflammatory cytokines, interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha),as well as nuclear factor kappaB (NF-kB).
  • $29
In Stock
Size
QTY
U 27391
U-27391, U27391
T26304106314-87-8
U 27391 is a metalloproteinase inhibitor. It acts by inhibits the action of human recombinant interleukin-1beta and glycosaminoglycan synthesis.
  • $1,520
6-8 weeks
Size
QTY
R-130823
T69451321344-32-5
R-130823 is a ighly selective inhibition against mitogen-activated protein kinase p38alpha (IC50=22 nM). The release of tumor necrosis factor-alpha, interleukin-1beta, -6 and -8 was inhibited in lipopolysaccharide-stimulated human blood pretreated by R-130823 , with IC50 values of 0.089, 0.066, 0.95 and 0.16 microM, respectively. R-130823 reduced the established hind paw swelling in rat adjuvant-induced arthritis, while methotrexate showed no suppression. In the same model, R-130823 ameliorated adjuvant-induced hyperalgesia with rapid onset and long duration comparable to a cyclooxygenase-2 inhibitor, celecoxib.
  • $2,120
8-10 weeks
Size
QTY